Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01908504 · ClinicalTrials.gov registry record · NA
Adaptive Pet Study
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 271
- Enrollment target
NCT01908504 is a NA study that has completed, run by Duke University. The registered enrollment target is 271 participants.
The verdict
NCT01908504, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 271 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the benefit of using positron emission tomography (PET) in addition to the standard (computed tomography) CT to plan radiation therapy for cancer treatment. The information from the PET-CT may allow the investigators to change the radiation plan or the delivery of the radiation to the tumor/tumor site such as the total dose of radiation or the size of the area to receive further radiation. Presently the use of PET scans to adjust radiation therapy during radiation treatment is not standard of care and is being investigated in this study.
Interventions
- OTHER PET-CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271 participants |
| Start Date | 2012-01 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01908504
The ClinicalTrials.gov registry entry for NCT01908504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 271 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET-CT is the first listed.
NCT01908504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01908504 about?
NCT01908504 is a clinical study titled "Adaptive Pet Study". The purpose of this study is to determine the benefit of using positron emission tomography (PET) in addition to the standard (computed tomography) CT to plan radiation therapy for cancer treatment. The information from the PET-CT may allow the investigators to change the radiation plan or the deliv...
What is the current status of trial NCT01908504?
This trial is currently completed. It is a NA study. The enrollment target is 271 participants. The study started on 2012-01. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01908504?
The interventions under investigation include: PET-CT (OTHER).
Who is sponsoring clinical trial NCT01908504?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.